PMID- 27694307 OWN - NLM STAT- MEDLINE DCOM- 20170606 LR - 20201209 IS - 1362-4962 (Electronic) IS - 0305-1048 (Print) IS - 0305-1048 (Linking) VI - 44 IP - 20 DP - 2016 Nov 16 TI - Distribution and effects of amino acid changes in drug-resistant alpha and beta herpesviruses DNA polymerase. PG - 9530-9554 AB - Emergence of drug-resistance to all FDA-approved antiherpesvirus agents is an increasing concern in immunocompromised patients. Herpesvirus DNA polymerase (DNApol) is currently the target of nucleos(t)ide analogue-based therapy. Mutations in DNApol that confer resistance arose in immunocompromised patients infected with herpes simplex virus 1 (HSV-1) and human cytomegalovirus (HCMV), and to lesser extent in herpes simplex virus 2 (HSV-2), varicella zoster virus (VZV) and human herpesvirus 6 (HHV-6). In this review, we present distinct drug-resistant mutational profiles of herpesvirus DNApol. The impact of specific DNApol amino acid changes on drug-resistance is discussed. The pattern of genetic variability related to drug-resistance differs among the herpesviruses. Two mutational profiles appeared: one favoring amino acid changes in the Palm and Finger domains of DNApol (in alpha-herpesviruses HSV-1, HSV-2 and VZV), and another with mutations preferentially in the 3'-5' exonuclease domain (in beta-herpesvirus HCMV and HHV-6). The mutational profile was also related to the class of compound to which drug-resistance emerged. CI - (c) The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. FAU - Topalis, D AU - Topalis D AD - Rega Institute for Medical Research, Department Microbiology and Immunology, KU Leuven, Minderbroedersstraat 10, 3000, Leuven, Belgium dimitrios.topalis@rega.kuleuven.be. FAU - Gillemot, S AU - Gillemot S AD - Rega Institute for Medical Research, Department Microbiology and Immunology, KU Leuven, Minderbroedersstraat 10, 3000, Leuven, Belgium. FAU - Snoeck, R AU - Snoeck R AD - Rega Institute for Medical Research, Department Microbiology and Immunology, KU Leuven, Minderbroedersstraat 10, 3000, Leuven, Belgium. FAU - Andrei, G AU - Andrei G AD - Rega Institute for Medical Research, Department Microbiology and Immunology, KU Leuven, Minderbroedersstraat 10, 3000, Leuven, Belgium graciela.andrei@rega.kuleuven.be. LA - eng PT - Journal Article PT - Review DEP - 20160929 PL - England TA - Nucleic Acids Res JT - Nucleic acids research JID - 0411011 RN - 0 (Antiviral Agents) RN - 0 (Viral Proteins) RN - EC 2.7.7.7 (DNA Polymerase I) RN - EC 2.7.7.7 (DNA Polymerase beta) RN - EC 2.7.7.7 (DNA-Directed DNA Polymerase) RN - EC 3.1.- (Exodeoxyribonucleases) RN - EC 3.1.11.- (DNA polymerase, Simplexvirus) SB - IM MH - *Amino Acid Substitution MH - Animals MH - Antiviral Agents/chemistry/pharmacology MH - Catalysis MH - Conserved Sequence MH - DNA Polymerase I/chemistry/*genetics/*metabolism MH - DNA Polymerase beta/chemistry/*genetics/*metabolism MH - DNA-Directed DNA Polymerase/chemistry/*genetics/*metabolism MH - *Drug Resistance, Viral MH - Enzyme Activation MH - Evolution, Molecular MH - Exodeoxyribonucleases/chemistry/*genetics/*metabolism MH - Herpesviridae/classification/drug effects/genetics MH - Humans MH - Mutation MH - Phenotype MH - Protein Interaction Domains and Motifs MH - Protein Multimerization MH - Structure-Activity Relationship MH - Viral Proteins/chemistry/*genetics/*metabolism PMC - PMC5175367 EDAT- 2016/10/04 06:00 MHDA- 2017/06/07 06:00 PMCR- 2016/09/29 CRDT- 2016/10/04 06:00 PHST- 2016/09/21 00:00 [accepted] PHST- 2016/09/13 00:00 [revised] PHST- 2016/05/04 00:00 [received] PHST- 2016/10/04 06:00 [pubmed] PHST- 2017/06/07 06:00 [medline] PHST- 2016/10/04 06:00 [entrez] PHST- 2016/09/29 00:00 [pmc-release] AID - gkw875 [pii] AID - 10.1093/nar/gkw875 [doi] PST - ppublish SO - Nucleic Acids Res. 2016 Nov 16;44(20):9530-9554. doi: 10.1093/nar/gkw875. Epub 2016 Sep 29.